Literature DB >> 10979805

New treatment options for Bartter's syndrome.

R Kleta, C Basoglu, E Kuwertz-Bröking.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2000        PMID： 10979805     DOI： 10.1056/NEJM200008313430915

Source DB:  PubMed          Journal:  N Engl J Med        ISSN： 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  10 in total

1.  Gitelman's syndrome.

Authors:  H M Ismail; T Jagadeesh; R V Bhat
Journal:  J R Soc Med       Date:  2001-06       Impact factor: 5.344

2.  Epilepsy, ataxia, sensorineural deafness, tubulopathy, and KCNJ10 mutations.

Authors:  Detlef Bockenhauer; Sally Feather; Horia C Stanescu; Sascha Bandulik; Anselm A Zdebik; Markus Reichold; Jonathan Tobin; Evelyn Lieberer; Christina Sterner; Guida Landoure; Ruchi Arora; Tony Sirimanna; Dorothy Thompson; J Helen Cross; William van't Hoff; Omar Al Masri; Kjell Tullus; Stella Yeung; Yair Anikster; Enriko Klootwijk; Mike Hubank; Michael J Dillon; Dirk Heitzmann; Mauricio Arcos-Burgos; Mark A Knepper; Angus Dobbie; William A Gahl; Richard Warth; Eamonn Sheridan; Robert Kleta
Journal:  N Engl J Med       Date:  2009-05-07       Impact factor: 91.245

3.  A highly conserved motif at the COOH terminus dictates endoplasmic reticulum exit and cell surface expression of NKCC2.

Authors:  Nancy Zaarour; Sylvie Demaretz; Nadia Defontaine; David Mordasini; Kamel Laghmani
Journal:  J Biol Chem       Date:  2009-06-17       Impact factor: 5.157

Review 4.  Salt-Losing Tubulopathies in Children: What's New, What's Controversial?

Authors:  Robert Kleta; Detlef Bockenhauer
Journal:  J Am Soc Nephrol       Date:  2017-12-13       Impact factor: 10.121

Review 5.  Bartter- and Gitelman-like syndromes: salt-losing tubulopathies with loop or DCT defects.

Authors:  Hannsjörg W Seyberth; Karl P Schlingmann
Journal:  Pediatr Nephrol       Date:  2011-04-19       Impact factor: 3.714

6.  Primary molecular disorders and secondary biological adaptations in bartter syndrome.

Authors:  Georges Deschênes; Marc Fila
Journal:  Int J Nephrol       Date:  2011-09-20

7.  Bartter syndrome-like phenotype in a patient with diabetes: a case report.

Authors:  Chamara Dalugama; Manoji Pathirage; S A M Kularatne
Journal:  J Med Case Rep       Date:  2018-08-17

8.  Clinical and diagnostic features of Bartter and Gitelman syndromes.

Authors:  Patrick R Walsh; Yincent Tse; Emma Ashton; Daniela Iancu; Lucy Jenkins; Marc Bienias; Robert Kleta; William Van't Hoff; Detlef Bockenhauer
Journal:  Clin Kidney J       Date:  2017-11-10

Review 9.  Cyclo-Oxygenase (COX) Inhibitors and Cardiovascular Risk: Are Non-Steroidal Anti-Inflammatory Drugs Really Anti-Inflammatory?

Authors:  Shanzana Khan; Karen L Andrews; Jaye P F Chin-Dusting
Journal:  Int J Mol Sci       Date:  2019-08-30       Impact factor: 5.923

10.  Bartter Syndrome Type 3: Phenotype-Genotype Correlation and Favorable Response to Ibuprofen.

Authors:  Xuejun Yang; Gaofu Zhang; Mo Wang; Haiping Yang; Qiu Li
Journal:  Front Pediatr       Date:  2018-05-30       Impact factor: 3.418
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.